| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |